Igniter has helped in the creation of 17 startup companies based on UW–Madison discoveries over the past three years.
Carl Ross has more than 26 years of experience advancing a wide range of cell and gene therapies, vaccines and therapeutic proteins into human clinical trials.
“I spent three years getting D2P going, and we did some good things in commercializing innovation from campus,” John Biondi says. “Now it’s time to turn it over to someone else who can take it to the next level.”
Researchers at the University of Wisconsin–Madison have developed a new measurement for the volume and activity of beta cells, the source of the sugar-regulating hormone insulin.
Discovery to Product (D2P) staff have mentored UW–Madison students, staff and faculty towards successful technology commercialization, including patenting, partnership with industry, and new company formation.
A University of Wisconsin–Madison spinoff that makes an innovative material designed to speed healing of serious burns has begun a large clinical trial for the “regenerative skin tissue” it has been developing since 2000.
Rabble LLC, a Madison startup with UW–Madison roots, offers software to libraries that presents the sound of local musicians in an easy-to-access format.
Companionship is as much a part of the attraction as the food, says co-founder Nathan Allman. Some of these relationships last for years.
A University of Wisconsin–Madison group that discovered a way to improve survival in fish farms has begun to unravel the mechanism behind their unexpected finding.
Five of the 13 finalists in the 2017 Governor’s Business Plan Contest have roots at UW–Madison. A business that makes an assist device to orient firefighters in smoky fire scenes won.
Technologies for converting non-edible biomass into chemicals and fuels traditionally made from petroleum exist aplenty. But when it comes to attracting commercial interest, these technologies compete financially with a petroleum-based production pipeline that has been perfected over the course of decades.
A UW–Madison professor has formed a startup to advance a streamlined chip design that will run up to 10 times faster than those now inside data centers.
A UW–Madison spinoff called Isomark is working to introduce a new infection-detection technology into hospital intensive care units.
Propeller Health makes an add-on device for inhalers that communicates with a smartphone that records the use of routine preventative medicines and “rescue” medications intended to open constricted airways.
UW-Madison students Shane Lian and Colin Harris have created a journaling app called “Journalit.” Submitted photo UW–Madison student Colin Harris, a senior in …
Ensodata, a UW–Madison spinoff that sifts through mountains of data from studies at sleep centers, received approval from the Food and Drug Administration on April 11 for its main product to be a medical device.
In a bit of high-tech judo, a UW–Madison spinoff has started selling a technology to transform phosphorus at wastewater treatment plants from a major headache into an asset.